Arrowstreet Capital, Limited Partnership Biocryst Pharmaceuticals Inc Transaction History
Arrowstreet Capital, Limited Partnership
- $120 Billion
- Q1 2025
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 194,152 shares of BCRX stock, worth $2.01 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
194,152
Previous 403,412
51.87%
Holding current value
$2.01 Million
Previous $3.03 Million
51.99%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BCRX
# of Institutions
292Shares Held
176MCall Options Held
721KPut Options Held
489K-
Vanguard Group Inc Valley Forge, PA21.7MShares$224 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$206 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$92.2 Million5.64% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.7MShares$89.9 Million1.06% of portfolio
-
State Street Corp Boston, MA7.81MShares$80.7 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.92B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...